Flamma named Best Global Pharmaceutical CDMO

Chignolo D’Isola, Bergamo, Italy – April 16, 2020 – Flamma has been named the Best Global Pharmaceutical CDMO according to the 2020 Biotechnology Awards.

Read more at: https://www.ghp-news.com/issues/biotechnology-awards-2020/

Flamma SpA (“Flamma”), a preeminent Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and commercializes small molecule Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, would like to thank the 2020 Biotechnology Awards for their selection of Flamma. This is a testament to the entire Flamma team.

The Flamma team is pictured above at our headquarters in Chignolo d’Isola, Italy